The association between plantar fasciitis and isolated gastrocnemius tightness by Nakale, Ngenomeulu Tufikifa
      
      
THE ASSOCIATION BETWEEN 
PLANTAR FASCIITIS AND 
ISOLATED GASTROCNEMIUS 
TIGHTNESS   
 
 
 
 
 
 
 
 
 
 
 
A research report submitted to the Faculty of Health Sciences, University of the 
Witwatersrand, in partial fulfilment of the requirements for the degree of  
Master of Medicine  
 
Johannesburg, May 2018
Dr Ngenomeulu Tufikifa Nakale 
BSc (UNAM), MBChB (UKZN) 
Orthopaedic Registrar 
University of Witwatersrand 
Division of Orthopaedic Surgery 
tn.nakale@gmail.com 
 
 
i 
 
Declaration 
 
I Ngenomeulu Tufikifa Nakale, declare that this Research Report is my own, unaided 
work. It is being submitted for the Degree of Master of Medicine in the branch of 
Orthopaedic Surgery at the University of the Witwatersrand, Johannesburg. It has not 
been submitted before for any degree or examination at any other University. 
 
………………………… 
 
 
…05th………day of  …June….2018…….in Park town, Johannesburg……… 
 
 
 
  
ii 
 
Dedication 
 
This research report is dedicated to my wife, parents and siblings for all their patience 
and understanding. 
  
iii 
 
Presentations 
 
Podium presentation at the South Africa Orthopaedic Association 66th Annual 
Congress: 4 – 7 September 2017, Port Elizabeth, South Africa. 
  
iv 
 
Publications  
 
Nakale NT, Strydom A, Saragas NP, Ferrao PNF. Association Between Plantar 
Fasciitis and Isolated Gastrocnemius Tightness. Foot Ankle Int. 2018; 39 (3): 271– 
277    
v 
 
Abstract 
 
Background: Plantar fasciitis is a painful inflammatory condition affecting the plantar 
aponeurosis of the foot. An association between plantar fasciitis and isolated 
gastrocnemius tightness has been postulated in published literature; however there 
have been few studies to prove this relationship. The aim of this study was to determine 
the association between plantar fasciitis and isolated gastrocnemius tightness. 
Material and Methods: This was a prospective cross-sectional cohort study over a 
three-month period comprising three groups: 45 patients with plantar fasciitis, 117 
patients with foot and ankle pathology other than plantar fasciitis and 61 patients 
without foot and ankle pathology. Patients were examined for the presence of isolated 
gastrocnemius tightness using the Silfverskiӧld test. The data were analysed using 
STATA version 14. Statistical tests included the chi-square test, Student’s t-test and 
analysis of variance (ANOVA). Statistical tests were two-sided at α = 0.05.  
Results: Overall, 101/223 (45.3%) patients had isolated gastrocnemius tightness, 
36/45 (80%) in the plantar fasciitis group, 53/117 (45.3%) in the other foot and ankle 
pathology group and 12/61 (19.7%) in the group without foot and ankle pathology. The 
difference in the prevalence of isolated gastrocnemius tightness amongst the three 
groups was statistically highly significant at p < 0.001. The prevalence of isolated 
gastrocnemius tightness was similar between acute and chronic symptoms of plantar 
fasciitis at 78.9% and 80.6%, respectively. 
Conclusion: There is a very strong association between plantar fasciitis and isolated 
gastrocnemius tightness, OR 16.3, 95% CI (6.1 – 42.5); p < 0.001 as well as a strong 
association between foot and ankle pathology other than plantar fasciitis and isolated 
gastrocnemius tightness, OR 3.4, 95% CI (1.6 – 7.0); p = 0.001 using the group without 
foot and ankle pathology as reference. 
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Level of Evidence: Level 2, Cross-sectional Cohort Study 
Key words: Plantar fasciitis, Silfverskiӧld test, Isolated gastrocnemius tightness 
 
 
 
 
  
vii 
 
Acknowledgements 
 
I would like to thank God the almighty, for the guidance and protection throughout the 
duration of this project. I am indebted to my supervisors, Dr Andrew Strydom, Prof Nick 
Saragas and Dr Paulo Ferrao for all their input and guidance from the beginning to the 
end of this study. I appreciate the input received from the research team in the 
department as well, Prof Faith Bischof, Dr Brenda Milner and Dr Maxwell Jingo. 
 
  
viii 
 
 
Table of Contents 
 
Declaration........................................................................................................................................... i 
Dedication ........................................................................................................................................... ii 
Presentations .................................................................................................................................... iii 
Publications ....................................................................................................................................... iv 
Abstract ............................................................................................................................................... v 
Acknowledgements ......................................................................................................................... vii 
List of Figures .................................................................................................................................... ix 
List of Tables ...................................................................................................................................... x 
Nomenclature .................................................................................................................................... xi 
1 Introduction and Literature Review ............................................................................................ 1 
1.1 Background ........................................................................................................................... 1 
1.2 Literature Review .................................................................................................................. 3 
1.3 Study Aim & Objectives ....................................................................................................... 6 
2 Methodology .................................................................................................................................. 6 
2.1 Study Design ......................................................................................................................... 6 
2.2 Sample size estimation ........................................................................................................ 8 
2.3 Materials and Methods ........................................................................................................ 8 
2.4 Data Collection ...................................................................................................................... 9 
2.5 Statistical Analysis ................................................................................................................ 9 
3 Results ......................................................................................................................................... 10 
4 Discussion ................................................................................................................................... 15 
5 Conclusion ................................................................................................................................... 18 
6 References .................................................................................................................................. 19 
 
7      Appendices 
 Appendix A: Postgraduate title approval letter ………………………………………….23 
Appendix B: Ethics clearance certificate…………………………………………………24 
 Appendix C: Data collection form ………………………………………………………...25 
 Appendix D: Summary of other foot and ankle pathology……………………………...26 
 Appendix E: Published Article……………………………………………………………..27  
ix 
 
 
List of Figures 
 
Figure 3.1: Prevalence of IGT amongst the three groups expressed as a percentage ......... 11 
Figure 3.2: Prevalence of other foot and ankle pathology (group 2) ..................................... 13 
 
 
  
x 
 
List of Tables 
 
Table 2.1: Inclusion and Exclusion criteria ............................................................................. 7 
Table 3.1 : Baseline characteristics: Prevalence of IGT ....................................................... 11 
Table 3.2: Univariate association between IGT, PF and other characteristics ...................... 12 
Table 3.3 : Multivariate association between IGT and PF .................................................... 14 
 
  
xi 
 
Nomenclature 
 
ACPS  Achilles-Calcaneus-Plantar System 
ANOVA  Analysis of Variance 
BOTOX Botulinum Toxin 
CMJAH Charlotte Maxeke Johannesburg Academic Hospital 
CI  Confidence Interval 
ESWT  Extra- corporeal Shockwave Therapy 
F & A  Foot & Ankle 
HREC  Human Research Ethics Committee 
ICU   Intensive Care Unit 
IGT  Isolated Gastrocnemius Tightness 
IQR  Interquartile Range 
OR  Odds Ratio 
PF   Plantar Fasciitis 
PRP  Platelet Rich Plasma 
SD  Standard Deviation 
 
 
 
 
 
1 
 
1 Introduction and Literature Review 
 
1.1 Background 
 
Plantar Fasciitis(PF) is defined as a localised inflammation and degeneration of the 
proximal plantar aponeurosis.1 The plantar fascia or aponeurosis is a dense fibrous 
structure that originates from the calcaneus, it runs under the fat pad and progresses 
distally to form five slips that inserts to each toe. The inflammation typically occurs at 
the point of origin near the medial tuberosity of the calcaneus, with histological 
appearance of a fibro fatty degeneration with associated micro tears and collagen 
necrosis. PF is a common problem, with a reported incidence of 11 -15% of all 
consultations at foot and ankle units amongst adults.2,3 Acute PF is diagnosed in 
patients presenting with symptoms for a duration less than nine months whereas 
chronic PF refers to presence of symptoms longer than nine months. The diagnosis of 
PF is generally a clinical one, based on typical history and clinical findings. The patient 
presents with foot pain worse in the morning with the first step or after a prolonged 
period of rest. The pain improves after mobilisation but may worsen if mobilisation is 
prolonged or is strenuous.  The location of the pain can also be highly suggestive, 
typically located on the plantar-medial aspect of the foot at the origin of the plantar 
fascia from the medial calcaneal tubercle. Passive dorsiflexion of the toes, the 
windlass test, reproduces the pain.4  
The plantar fascia is an important part of the normal foot and ankle biomechanics, 
serving to sustain the arch of the foot whilst also stabilising the joints of the foot. 
Together with the other structures in the foot, they form an arch-like triangular structure 
or truss. The arch of the truss is formed by the calcaneus, mid tarsal joints and 
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metatarsals, whilst the plantar fascia acts like a windlass between the calcaneus and 
phalanges, tightening like a rope when toes are lifted on a weight bearing foot. This is 
called the windlass mechanism as initially described by Hicks.5 
Studies have shown that there is an anatomic, histologic, mechanical and functional 
link between the plantar fascia and the Achilles tendon through the calcaneal 
tuberosity. 6,7,8 The extent of the connection and the duration remains a topic of debate. 
Arandes and Viladot (1953) postulated that the connection is primarily present in 
childhood up to the age of seven years when the secondary ossification centre 
appears inside the fibres that connect the Achilles tendon and the plantar fascia.9 
Other authors have presented evidence in support of the idea that this anatomic 
connection could vary with the plantar fascia in neonates which is lost in adults and 
absent in the elderly.10,11 The concept of an independent functional unit, the Achilles-
Calcaneus-Plantar System (ACPS), described in earlier texts was popularised by 
Arandes and Viladot (1953).9 The ACPS’s main function is to transmit Achilles tendon 
force to distal structures that will add to the short flexors. 
Another model, the sagittal foot model presented by Kirby (2009) demonstrates the 
mechanical connection of the gastrocnemius muscle by means of the Achilles tendon 
as well as the plantar fascia. This model divides the forces acting on the foot and ankle 
into external forces (gravity and ground reaction forces) and internal forces (Achilles 
tendon and plantar fascia tensional forces) to explain the mechanical behaviour of the 
foot and ankle.12 Achilles tendon tensional force leads to hindfoot plantar flexion and 
forefoot dorsiflexion with an associated increase in ground reaction forces which 
naturally tends to flatten the arch of the foot. The flattening force is counteracted by 
tension of the plantar structures, particularly the plantar fascia, preventing arch 
collapse. Kirby’s model has been widely supported by various cadaveric and finite 
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element analysis studies.13,14,15 It stands to reason that increased tensional forces in 
the Achilles tendon, leads to increased tensile forces on the plantar structures, 
particularly the plantar fascia, predisposing to the development of PF. 
 
1.2 Literature Review 
 
Various authors have demonstrated that increased tensional forces in the Achilles 
tendon are translated to the plantar structures, particularly the plantar fascia.13, 14,15, 
16,17, 
Huerta (2014) described gastrocnemius tightness as increased ankle joint stiffness in 
a dorsiflexion direction, clinically manifesting as an inability to dorsiflex the foot beyond 
neutral and is primarily as a consequence of contracture of the gastrocnemius-soleus 
complex.6 The gastrocnemius muscle is the significant contributor to gastrocnemius-
soleus contracture since it crosses the knee, ankle and subtalar joints.18 
Gastrocnemius-soleus contracture can be congenital or acquired and various factors 
have been noted to result in this condition ranging from prolonged resting posture 
(supine, prone) e.g. in patients with prolonged Intensive Care Unit (ICU) stay6,19 to 
continuous use of high heels.6 
It is crucial to differentiate between the origins of the tightness being either isolated 
gastrocnemius tightness (IGT) or combined gastrocnemius-soleus tightness as this 
has clinical implications, and will help guide correct management. With IGT, 
management options can be aimed at addressing the gastrocnemius alone rather than 
the gastrocnemius-soleus complex, reducing procedure-related morbidity to the 
patient. The Silfverskiӧld test, originally described by Nils Silfverskiӧld in 1924, is a 
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clinical test utilised to make this differentiation.20 The test is performed with the patient 
sitting or lying spine on the examination couch. The examiner’s one hand is placed at 
the heel, whilst the other hand is positioned around the midfoot to stabilise the 
talonavicular joint. The hindfoot is locked in varus and the ankle pushed into maximal 
dorsiflexion. The maximal dorsiflexion of the ankle is compared with the knee extended 
and the knee flexed. If the maximal dorsiflexion improves when the knee is flexed, as 
compared to extended, then the test is deemed positive.21 
 
IGT is defined as maximal ankle dorsiflexion that is less than 5° with the knee in full 
extension that corrects when the knee is flexed to 90°; a positive Silfverskiӧld test. 
Gastrocnemius-soleus tightness is present when there is less than 10° of maximal 
dorsiflexion regardless of knee position.21 
There are few published studies where the authors assessed the relationship between 
gastrocnemius tightness and PF. 
Kibler et al. (1991) assessed 43 athletes’ feet with PF. Thirty-seven of the forty-three 
patients showed reduced range of ankle dorsiflexion in the affected limb compared 
with the unaffected side.22 
DiGiovanni et al. (2002) confirmed a connection between patients with forefoot and 
midfoot pathology and decreased ankle dorsiflexion. The Silfverskiӧld test was 
performed in 34 patients with midfoot/forefoot pathology and a similar number without 
foot and ankle pathology as the control group.21 They found that patients with forefoot 
and/or midfoot symptoms demonstrated more IGT (61%) compared to the control 
group (24%). The study then concluded that IGT contributes to the development of 
forefoot and/or midfoot conditions in the normal population.  
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Patel et al. (2011) published what is believed to have been the first study to 
prospectively evaluate the association between PF and IGT. This study evaluated 254 
patients diagnosed with acute and chronic PF to see whether they had associated 
limited ankle dorsiflexion or not. The findings were that 83% of the study group had 
limited ankle dorsiflexion of which 57% had a positive Silfverskiӧld test, 26% had 
gastrocnemius-soleus contracture and 17% did not have limited dorsiflexion. This 
study concluded that reduced ankle dorsiflexion, and in particular IGT, is a common 
occurrence in patients with PF.23  
More recently, Bolivar et al. (2013) found significant differences between a group of 
50 patients with PF and a control group for the tests used to evaluate tightness of 
posterior lower limb muscles, which included the Silfverskiӧld test (p < 0.001). The 
Silfverskiӧld test was found to be 100% sensitive and 96% specific as a diagnostic test 
for posterior muscle tightness.19 The findings of this study were in keeping with earlier 
studies and demonstrated tightness of the posterior muscles associated with PF.  
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1.3 Study Aim & Objectives 
 
The aim of this study was to determine the association between PF and IGT. The 
hypothesis was that there is an association between IGT and PF. 
 
Objectives: 
• To compare the prevalence of IGT in patients with PF, other foot and ankle 
pathologies and in patients with no foot and ankle pathology.  
• To determine some of the risk factors associated with PF. 
 
2 Methodology 
 
2.1 Study Design  
 
This was a prospective cross-sectional cohort study consisting of three groups of 
patients. Group 1, Group 2 and Group 3 comprised patients with a clinical diagnosis 
of PF, patients with foot and ankle pathology other than PF, and patients with no foot 
and ankle pathology respectively. This study was performed between 01 August and 
31 October 2016. The patients in Group 1 and 2 were recruited from the University of 
the Witwatersrand (Wits) Orthopaedic Foot and Ankle Unit at Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) and Netcare Linksfield Private Hospital in 
Johannesburg, South Africa. The third group (Group 3) of patients without foot and 
ankle pathology were recruited from the upper limb orthopaedic clinic at CMJAH. 
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Ethics approval for this study was obtained from the Wits Human Research Ethics 
Committee (Medical) (Reference: M160601) (see Appendix A).  
The inclusion and exclusion criteria for the three groups are outlined in the Table 
below: 
 
Table 2.1: Inclusion and Exclusion criteria 
 Group 1 Group 2 Group 3 
Inclusion 
criteria 
• Diagnosis of PF 
• Age ≥ 18 years 
• Diagnosis of 
foot and ankle 
pathology 
other than PF 
• Age ≥ 18 
• No foot 
ankle 
pathology 
• Age ≥ 18 
Exclusion 
criteria 
• Previous 
gastrocnemius 
recession 
• PF and other 
associated foot and 
ankle pathology 
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2.2 Sample size estimation 
 
A sample size and power estimation performed utilising STATA (Version 14), 
assuming an IGT prevalence of 60% for the PF group and 20% for the group with no 
foot pathology, determined a total sample size of 46, with at least 23 examinations in 
each group in order to detect a prevalence difference between the groups.  
Similarly, assuming an IGT prevalence of 45% for the other foot pathology group and 
20% for the no foot pathology group, sample size and power estimation performed 
utilising STATA (Version 14) determined a total sample size of 108 patients with at 
least 54 examinations in each group to detect a prevalence difference between the 
groups.  
2.3 Materials and Methods  
 
PF was diagnosed clinically with the exclusion of other causes of heel pain. The 
Silfverskiӧld test was performed as described in the literature review. The test was 
deemed to be positive if the difference in range of dorsiflexion was more than 10°.  
A total of 45 patients were included in group 1, of which five had bilateral pathology. 
Only one side was considered for the study, the more symptomatic side. Group 2 
included 117 patients with other foot and ankle pathology, whereas in group 3, 61 
patients without foot and ankle pathology were assessed.  
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2.4 Data Collection 
 
The data were collected by the principal investigator and the supervisors, using a 
data collection form (see Appendix C).  
 
2.5 Statistical Analysis 
 
The data were analysed using STATA (Version 14) statistical software (STATA 
Corporation, College Station, TX USA).  
 
The following variables were included in the analysis: 
• Age 
• Gender 
• Foot examined (Left /Right /both) 
• Presence of isolated gastrocnemius 
• Presence of PF 
• Other foot or ankle pathologies 
• Duration of symptoms for PF 
• Occupation.  
 
Exploratory data analysis of categorical and continuous variables included frequency 
tables and histograms of continuous variables to determine the distribution of the data.  
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Simple descriptive statistics were used to characterise the study population. Normally 
distributed continuous data were summarised by mean and standard deviation (SD), 
and non-normally distributed continuous data by median and interquartile range (IQR). 
Categorical data were summarised as a number and proportion. Statistical tests 
included the chi-square test, the Student’s t-test for the comparison of means between 
two groups and Analysis of variance (ANOVA) for more than two groups. Logistic 
regression was used to determine the association between IGT and PF, age and 
gender were considered as potential confounding variables and adjusted for in this 
analysis. Statistical tests were two-sided at α = 0.05. 
3 Results 
 
The study population comprised 223 patients across the three groups. The mean age 
of the 223 patients was 52.8 years (SD 15.0) and 153/223 (68.6%) were female. Group 
1 comprised of 45/223 (20.2%) patients, group 2 comprised of 117 (52.5%) patients 
whilst group 3 had 61 (27.3%) patients. 
More females than males were included in this study i.e. 153/223 (68.6%). There was 
no statistically significant difference in the gender proportions across the three groups 
with 34/45 (75.6%) females in the PF group, 79/117 (67.5%) in the other foot/ankle 
pathologies and 40/61 (65.6%) in the no foot/ankle pathologies; p = 0.513. The mean 
age was similar across the three groups, 52.4 (SD 11.4) in group 1, 53.1 (SD 16.3) in 
group 2 and 52.3 (SD 14.8) group 3; p = 0.621. These findings are tabulated in Table 
3.1. 
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Table 3.1 : Baseline characteristics: Prevalence of IGT 
Summary statistics of the prevalence of IGT and its association with PF, 
adjusted for the possible effect of gender and age 
Variable All Group 1: 
PF 
Group 2: 
Other 
Foot/ankle 
Pathology 
Group 3: No 
Foot/ankle 
Pathology 
Total 223 45 (20.2%) 117 (52.5%) 61 (27.3%) 
Gender 
Male 
Female 
 
70 (31.4%) 
153 (68.6%) 
 
11 (24.4%) 
34 (75.6%) 
 
38 (32.5%) 
79 (67.5%) 
 
21 (34.4%) 
40 (65.6%) 
Age  
Mean (SD) 
 
52.8 (15.0) 
 
52.4 (11.4) 
 
53.1 (16.3) 
 
52.3 (14.8) 
IGT 101 (45.3%) 36 (80.0%) 53 (45.3) 12 (19.7%) 
 
 
Overall 101/223 (45.3%) patients had a positive result for IGT, 36/45 (80.0%) in the 
PF group, 53/117 (45.3%) in the other foot/ankle pathology group and 12/61 (19.7%) 
in the no foot/ankle pathology group (see Figure 3.1 and Table 3.2); this was a 
statistically highly significant result (p < 0.001). 
  
Figure 3.1: Prevalence of IGT amongst the three groups expressed as a percentage 
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Table 3.2: Univariate association between IGT, PF and other characteristics 
UNIVARITE ASSOCIATION BETWEEN (IGT), PF AND OTHER 
CHARACTERISTICS 
 All 
N = 223 
IGT 
N = 101 
(45.3%) 
No IGT 
122 
(54.7%) 
P 
value 
Gender 
Male 
Female 
 
70 (31.4%) 
153 (68.6%) 
 
28 (27.7%) 
73 (72.3%) 
 
42 (34.4%) 
80 (65.6%) 
 
0.283 
Age  
Mean (SD) 
 
52.8 (15.) 
 
53.5 (13.7) 
 
52.1 (15.1) 
 
0.500 
Foot/ankle Pathology 
PF 
Other Foot/ankle Pathology 
No Foot/ankle pathology 
 
45 (20.2%) 
117 (52.5%) 
61 (27.3%) 
 
36 (80.0%) 
53 (45.3%) 
12 (19.7%) 
 
9 (20.0%) 
64 (54.7%) 
49 (80.3%) 
 
<0.001 
 
 
 
The median duration of symptoms in the PF group was 12 months (interquartile range 
(IQR) 7 – 24 months). Thirty-eight (38) % of the cases presented with acute symptoms, 
i.e. less than nine months duration whereas 62% presented with chronic symptoms. 
The prevalence of IGT was similar between patients with acute and chronic symptoms 
at 78.9% and 80.6%, respectively. 
The top five most prevalent diagnoses in the group 2 were osteoarthritis 15 (12.8%), 
hallux valgus 13 (11.1%), tendinopathy 12 (10.3%), pes plano-valgus 12 (10.3%) and 
neuromas 11 (9.4%) (see Figure 3.2). The other less prevalent diagnoses were 
combined in one group, and represented 19.7% of all cases in group 2. These other 
diagnoses are tabulated in Table C.1 in Appendix C. 
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Figure 3.2: Prevalence of other foot and ankle pathology (group 2) 
 
In the patients with a positive result for IGT, the prevalence was similar in the left foot 
compared to the right foot; 3/101 (3%) were positive in both feet, 50 (49.5%) were 
positive in the left foot and 48 (47.5%) in the right foot. 
The multivariate analysis adjusted for the effect of age and gender shows that there is 
a very strong association between PF and IGT, OR 16.3 95% CI1 (6.1 – 42.5); p < 
0.001 and a strong association between other foot/ankle pathologies and IGT, OR 3.4 
95% CI (1.6 – 7.0); p = 0.001, using the group with no foot pathology as the reference 
(see Table 3.3). 
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Table 3.3 : Multivariate association between IGT and PF 
 
  
                                                          
2 OR = odds ratio 
MULTIVARIATE ASSOCIATION BETWEEN IGT and PF 
 All 
N = 223 
IGT 
N = 101 
(45.3%) 
No IGT 
122 (54.7%) 
OR2 P 
value 
Gender 
Male 
Female 
 
70 (31.4%) 
153 (68.6%) 
 
28 (27.7%) 
73 (72.3%) 
 
42 (34.4%) 
80 (65.6%) 
 
0.8 (0.4 – 1.5) 
Reference 
 
0.479 
Age  
Mean (SD) 
 
52.8 (15.0) 
 
53.5 (13.6) 
 
52.0 (15.9) 
 
1.0 (0.9 – 1.0) 
 
0.460 
Foot/ankle Pathology 
PF 
Other Foot/ankle Pathology 
No Foot/ankle pathology 
 
45 (20.2%) 
117 (51.5%) 
61 (27.3%) 
 
36 (80.0%) 
53 (45.3%) 
12 (19.7%) 
 
9 (20.0%) 
64 (54.7%) 
49 (80.3%) 
 
16.3 (6.1 – 42.5) 
3.4 (1.6 – 7.0) 
Reference 
 
<0.001 
0.001 
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4 Discussion 
 
This study achieved the aims and objectives which were to determine the association 
between PF and IGT by comparing the prevalence of IGT across the three groups. 
This study was adequately powered to detect differences in the prevalence between 
the three groups (PF, other Foot/ankle pathology and No Foot/ankle pathology). 
Statistical analyses showed that differences in gender and age across the three 
groups were not statistically significant. 
The average age of patients with PF was 52.4 years. This falls within the reported 
peak age range for this condition, which is 40 – 60 years24,25,26 with almost two thirds 
of the affected patients being female (74%). The left and right foot were equally 
affected and no differences were found between chronicity of symptoms and IGT. 
The results indicate a very strong association between IGT and PF. Possible risk 
factors for developing PF identified in this study include gender (female), middle age 
(41-64), and reduced ankle dorsiflexion, some of which were identified in previous 
studies. 27,28,29,  
The strong association between PF and IGT is not surprising, as previous studies have 
demonstrated the embryonic and  functional connection between the plantar fascia 
and the gastrocnemius-soleus complex.6, 7, 8, 12, 18 Increased tensional forces on the 
Achilles tendon, e.g. due to gastrocnemius tightness will result in increased 
transmission of forces on the plantar fascia in the stance phase of walking, causing 
PF. 
The results also confirm a strong association between patients with other foot and 
ankle pathology and IGT, with a prevalence of 45.3% in this group. Patients without 
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foot and ankle pathology are less likely to have IGT, with a prevalence of IGT in this 
group of 19.7% compared to the other two groups. 
These findings are consistent with existing evidence, and support the notion that IGT 
is a strong risk factor for PF and contributes to the development of other foot and ankle 
pathology. Patel et al. (2011) reported an incidence of 83% of reduced ankle 
dorsiflexion in their study, looking at patients with PF, of which 57% had IGT.23 
Similarly, DiGiovanni et al. (2002) found a prevalence rate IGT of between 65 - 83% 
in patients with other foot and ankle pathology.21 This current study shows that IGT 
does not invariably produce foot or ankle pathology as 19.7% of patients without foot 
and ankle pathology will have a positive Silfverskiӧld test. 
 
Evidence suggests that a good proportion of patients with PF improve over time with 
conservative management alone. Therefore, for the management of PF, non-operative 
options must be exhausted prior to proceeding to operative techniques. The non-
operative options have been well described in literature and range from patient-
oriented modalities particularly, rest, activity modification, ice packs and analgesia to 
physical modalities such as stretching and foot orthotics. Orthotics commonly 
employed in the management of PF include night splints, viscoelastic heel cups, arch 
supports etc. Failure to respond to these modalities can be followed by injections with 
steroids30, Botulinum-toxin (Botox)31,32 or Platelet Rich Plasma (PRP)33,34, casting35,36 
or extra corporeal shockwave therapy (ESWT).37,38, 39. However, there will still be a 
subset of patients that fail to satisfactorily respond to the non-surgical modalities and 
subsequently develop chronic, recalcitrant symptoms that requires surgical 
intervention. Surgical options include plantar fasciotomy or gastrocnemius soleus 
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complex lengthening done by either lengthening both the gastrocnemius and the 
soleus muscles or the gastrocnemius muscle alone. Based on the findings of this and 
previous studies that most patients with PF display IGT, a gastrocnemius muscle 
release alone will seem to be adequate to allay the symptoms, possibly with reduced 
procedure related morbidity. This view is supported by Aronow et al. (2006).18 Taking 
it a step further, Abbassian et al. (2012) advocated for the proximal release of the 
medial head of gastrocnemius alone.40 The authors argue that the medial head 
contributes a greater deal to generating plantarflexion power compared to the lateral 
head, and its release alone achieves satisfactory correction.  
With the findings of this study and previous studies showing a strong association 
between IGT and PF, it will be interesting to find out how IGT status changes over time 
as PF resolves. Therefore, future studies could assess the improvement of the 
Silfverskiӧld test over time as PF resolves.  
 A limitation of this study is a relatively small study population even though it was 
adequately powered. A larger cohort would have been more representative. This study 
also did not assess some of the risk factors known to contribute to PF, e.g. body mass 
index, occupation and foot morphology like cavovarus foot and pes planovalgus.41  
The implications of the findings of this study suggest that IGT should be actively sought 
out early and treated, whether non-operatively or operatively when managing PF and 
other pathologies.  
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5 Conclusion 
 
This study suggests a very strong association between IGT and PF, as well as a strong 
association between IGT and other foot and ankle pathology. This study also points to 
female gender and middle age (41 – 64) as additional risk factors for PF. 
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Appendix D: Summary of other foot & ankle pathology  
Table C.1: Summary of other foot & ankle pathology 
Table 
foot/ankle pathology h |      Freq.     Percent        Cum. 
----------------------+----------------------------------- 
            OCD talus |          3        2.56        2.56 
         ankle sprain |          5        4.27        6.84 
       cavovarus foot |          3        2.56        9.40 
            flat foot |         12       10.26       19.66 
             fracture |          6        5.13       24.79 
        hallux valgus |         13       11.11       35.90 
           hammer toe |          6        5.13       41.03 
              neuroma |         11        9.40       50.43 
      osteoarthritis |         15       12.82       63.25 
            
peripheral neuropathy |          3        2.56       85.47 
 rheumatoid arthritis |          5        4.27       89.74 
         tendinopathy |         12       10.26      100.00 
    Ankle Instability |          2        8.70        8. 
Ankle fracture malunion |        1        4.35       13.04 
  Freiberg Infraction |          2        8.70       21.74 
      Gouty arthritis |          1        4.35       26.09 
       Hallux rigidus |          1        4.35       30.43 
Heel Fat pad contusion |         2        8.70       39.13 
Lesser toe deformities |         1        4.35       43.48 
      Ligament sprain |          1        4.35       47.83 
      Lisfranc Injury |          1        4.35       52.17 
 Peroneus brevis tear |          1        4.35       56.52 
Peroneal enthesopathy |          1        4.35       60.87 
 Peroneal subluxation |          1        4.35       65.22 
 Plantar Fibromatosis |          2        8.70       73.91 
Posterior ankle impingement |    1        4.35       78.26 
          Shin pain |            1        4.35       82.61 
Subluxating Peroneal tendons |   1        4.35       86.96 
Tibialis posterior impingement | 1        4.35       91.30 
Tibialis Anterior Tendinitis |   1        4.35       95.65 
Venous Insufficiency |           1        4.35      100.00 
 
----------------------+----------------------------------- 
                Total |        117      100.00  
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Plantar fasciitis is a common diagnosis, with a reported 
incidence of 11% to 15% of all consultations at foot and 
ankle units among adults.33,41 Plantar fasciitis is defined as 
a localized inflammation and degeneration of the proximal 
plantar fascia.29 The plantar fascia has an important func-
tion in normal foot and ankle biomechanics, serving to sus-
tain the arch of the foot while also stabilizing the joints of 
the foot. Studies have shown that there is an anatomic, his-
tologic, mechanical, and functional link between the plantar 
fascia and the Achilles tendon through the calcaneal tuber-
osity.23,28,46 The extent of the connection and the duration 
remains a topic of debate. Achilles tendon tensional force 
leads to hindfoot plantarflexion and forefoot dorsiflexion 
with an associated increase in ground reaction forces, which 
naturally tends to flatten the arch of the foot. Increased ten-
sional forces in the Achilles tendon mainly lead to increased 
tensile forces on the plantar structures, particularly the plan-
tar fascia, predisposing to the development of plantar fasci-
itis, which has been suggested by various authors.6,10-12,50
Huerta23 described gastrocnemius tightness as increased 
ankle joint stiffness in dorsiflexion, clinically manifesting 
as an inability to dorsiflex the foot beyond neutral and is 
primarily a consequence of contracture of the gastrocne-
mius-soleus complex. The gastrocnemius muscle is the 
major contributor to gastrocnemius-soleus contracture since 
it crosses the knee, ankle, and subtalar joints.4
In assessing patients with gastrocnemius-soleus complex 
tightness, it is crucial to differentiate between the origin of 
the tightness being either isolated gastrocnemius tightness 
(IGT) or combined gastrocnemius-soleus tightness as this 
has clinical implications and will help guide correct man-
agement. In the Grand Rapids Arch Collapse Classification 
proposed by Anderson et al,3 IGT is described as the first of 
5 stages (type 1) of a cascade of events leading to a progres-
sive collapse of the arch. This type 1 is a precollapse defor-
mity that can initiate conditions such as Achilles 
tendinopathy, plantar fasciitis, metatarsalgia, and arch pain.
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Abstract
Background: An association between plantar fasciitis and isolated gastrocnemius tightness (IGT) has been postulated in 
the literature; however, there have been few studies to prove this relationship. This prospective cross-sectional cohort 
study was aimed at determining the association between plantar fasciitis and IGT.
Methods: Three groups comprising 45 patients with plantar fasciitis (group 1), 117 patients with foot and ankle pathology 
other than plantar fasciitis (group 2), and 61 patients without foot and ankle pathology (group 3) were examined for the 
presence of IGT using the Silfverskiöld test. Statistical tests included chi-square test, Student t test, and analysis of variance.
Results: Of the patients, 101 (45.3%) had IGT: 36 (80%) in group 1, 53 (45.3%) in group 2, and 12 (19.7%) in group 3. The 
difference in IGT prevalence between the groups was statistically significant at P < .001. The prevalence of IGT was similar 
between acute and chronic plantar fasciitis at 78.9% and 80.6%, respectively.
Conclusion: There was a very strong association between plantar fasciitis and IGT using group 3 as a reference. This 
study suggests that IGT should be actively sought out and managed in patients with plantar fasciitis.
Level of Evidence: Level II, cross-sectional cohort prospective study.
Keywords: plantar fasciitis, isolated gastrocnemius tightness, Silfverskiöld test
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With IGT, management options can be aimed at address-
ing the gastrocnemius alone rather than the gastrocnemius-
soleus complex, reducing procedure-related morbidity to 
the patient. The Silfverskiöld test, originally described by 
Nils Silfverskiöld in 1924, is a clinical test used to make 
this differentiation.45 IGT is defined as maximal ankle dor-
siflexion that is less than 5 degrees with the knee in full 
extension that corrects when the knee is flexed to 90 
degrees, a positive Silfverskiöld test. Gastrocnemius-soleus 
tightness is present when there is less than 10 degrees of 
maximal dorsiflexion regardless of knee position.17
There are limited published studies in which the authors 
assessed the relationship between IGT and plantar fasciitis, 
most of which demonstrated a relationship between IGT 
and plantar fasciitis.7,17,26,40 IGT has a reported incidence of 
between 24% and 44% among the normal population with-
out foot and ankle pathology.17 The aim of this study was to 
determine the association between plantar fasciitis and IGT 
and to compare the prevalence of IGT in patients with plan-
tar fasciitis, other foot and ankle pathologies, and patients 
with no foot and ankle pathology. Our hypothesis was that 
there would be a marked association between IGT and plan-
tar fasciitis.
Methods
This prospective cross-sectional cohort study consisted of 3 
groups of patients. Group 1, group 2, and group 3 com-
prised patients with a clinical diagnosis of plantar fasciitis, 
patients with foot and ankle pathology other than plantar 
fasciitis, and patients with no foot and ankle pathology, 
respectively. This study was performed between August 1, 
2016, and October 31, 2016. Patients for group 3 were 
recruited from the orthopedic upper limb trauma clinic. 
Ethics approval for this study was obtained from our institu-
tion’s ethics committee (medical) prior to the commence-
ment of data collection, and informed consent was obtained 
from all patients. The inclusion and exclusion criteria for 
the 3 groups are outlined in Table 1.
The study population comprised 223 patients across the 
3 groups. The mean age of the patients was 52.8 (range, 21 
to 82) years. Group 1 was composed of 45 (20.2%) patients, 
of which 5 had bilateral pathology. Only 1 side was 
considered for the study, the more symptomatic side. Group 
2 was composed of 117 (52.5%) patients, and group 3 had 
61 (27.3%) patients. Women accounted for 68.6% (153) of 
the patients. There was no statistically significant difference 
in the gender proportions across the 3 groups, with 34 
(75.6%) women in group 1, 79 (67.5%) in group 2, and 40 
(65.6%) in group 3; P = .513. The mean age was similar 
across the 3 groups, 52.4 (SD, 11.4) in group 1, 53.1 (SD, 
16.3) in group 2, and 52.3 (SD, 14.8) group 3; P = .621. 
These findings are tabulated in Table 2.
Plantar fasciitis was diagnosed clinically with the exclusion 
of other causes for heel pain. Although there have been reports 
on the usefulness of magnetic resonance imaging (MRI) in 
diagnosing plantar fasciitis,1 clinical diagnosis remains key,21 
and MRI is often indicated only in cases of recalcitrant plantar 
fasciitis and to rule out other pathologies.13,49
The Silfverskiöld test was performed with the patient 
supine, assessing the range of ankle dorsiflexion with the 
knee in full extension and in 90 degrees of flexion. The test 
was deemed to be positive if the difference in range of dor-
siflexion was 10 degrees or more using a goniometer.
Statistical Analysis
The data were collected by the principal investigator and 
the supervisors. The data were analyzed using STATA (ver-
sion 14) statistical software (STATA Corporation, College 
Station, TX). Exploratory data analysis of categorical and 
continuous variables included frequency tables and histo-
grams of continuous variables to determine the distribution 
of the data. Simple descriptive statistics were used to char-
acterize the study population. Normally distributed continu-
ous data were summarized by mean and standard deviation 
(SD), and nonnormally distributed continuous data by 
median and interquartile range (IQR). Categorical data 
were summarized as a number and proportion. Statistical 
tests included the chi-square test, Student t test for the com-
parison of means between 2 groups, and analysis of vari-
ance for more than 2 groups. Logistic regression was used 
to determine the association between IGT and plantar fasci-
itis; age and gender were considered as potential confound-
ing variables and adjusted for in this analysis. Statistical 
tests were 2-sided at α = .05.
Table 1. Inclusion and Exclusion Criteria.
Group 1 Group 2 Group 3
Inclusion criteria • Diagnosis of plantar fasciitis
• Age ≥18 y
•  Diagnosis of foot and ankle 
pathology other than plantar fasciitis
• Age ≥18 y
• No foot ankle pathology
• Age ≥18 y
Exclusion criteria • Previous gastrocnemius recession
•  Concurrent diagnosis of plantar 
fasciitis and other foot and ankle 
pathology
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A sample size and power estimation was calculated using 
STATA (version 14). To determine a statistically significant 
difference in the proportion positive for IGT in group 1 
compared with group 3, a prevalence of 60% was assumed 
for group 1 and 20% for group 3. STATA calculated that we 
would need a total sample size of 46, with at least 23 exami-
nations in each group (α = .05, delta = 0.4, and power = 
0.8). Similarly, to determine a statistically significant differ-
ence in the proportion positive for IGT in group 2 compared 
with group 3, a prevalence of 45% was assumed for group 2 
and 20% for group 3. STATA calculated that we would need 
a total sample size of 108, with at least 54 examinations in 
each group (α = .05, power = 0.8, delta = 0.25).
Results
The primary outcome variable was presence of IGT as mea-
sured by the Silfverskiöld test. Overall, 101 (45.3%) patients 
had a positive Silfverskiöld test, 36 (80.0%) in group 1, 53 
(45.3%) in group 2, and 12 (19.7%) in group 3 (Figure 1; 
Table 3). The difference in the 3 groups was statistically 
significant (P < .001).
The median duration of symptoms in the plantar fasciitis 
group was 12 months (IQR, 7 to 24 months). Thirty-eight 
percent of cases presented with acute symptoms (ie, less 
than 9 months’ duration), whereas 62% presented with 
chronic symptoms. The prevalence of IGT was similar 
between patients with acute and chronic symptoms at 78.9% 
and 80.6%, respectively.
The top 5 most prevalent diagnoses in group 2 were 
osteoarthritis in 15 (12.8%), hallux valgus in 13 (11.1%), 
tendinopathy in 12 (7 Achilles, 3 peroneal, 2 tibialis ante-
rior; 10.3%), pes planovalgus in 12 (10.3%), and neuromas 
in 11 (9.4%; Figure 2). The other less prevalent diagnoses 
were combined into one group and represented 19.7% of all 
cases in group 2.
In the patients with a positive test for IGT, the preva-
lence was similar in the left foot compared with the right 
foot; 3 (3%) were positive in both feet, 50 (49.5%) were 
positive in the left foot, and 48 (47.5%) in the right foot.
The multivariate analysis adjusted for the effect of age 
and gender shows that there was a very strong association 
between plantar fasciitis and IGT (odds ratio [OR], 16.3; 
95% confidence interval [CI], 6.1 to 42.5; P < .001) and a 
strong association between other foot/ankle pathologies and 
IGT (OR, 3.4; 95% CI, 1.6-7.0; P = .001) using the group 
with no foot pathology as the reference (Table 4).
Discussion
The association between IGT and plantar fasciitis has previ-
ously been reported in the literature. Authors have also 
compared the prevalence of IGT between patients with 
plantar fasciitis and patients with other foot and ankle 
pathologies. To our knowledge, our study is the first to com-
pare the prevalence of IGT between 3 groups as described 
earlier. The results indicate a very strong association 
between IGT and plantar fasciitis. Possible risk factors for 
developing plantar fasciitis identified in this study include 
gender (female), middle age (41 to 64 years), and IGT, 
some of which were identified in previous studies.43,47,52 
The strong association between plantar fasciitis and IGT is 
not surprising, as previous studies have demonstrated the 
embryonic and functional connection between the plantar 
Table 2. Baseline Characteristics: Prevalence of Isolated Gastrocnemius Tightness (IGT).a
Variable All Group 1: Plantar Fasciitis
Group 2: Other Foot/
Ankle Pathology
Group 3: No Foot/Ankle 
Pathology
Total 223 45 (20.2%) 117 (52.5%) 61 (27.3%)
Gender
 Male 70 (31.4%) 11 (24.4%) 38 (32.5%) 21 (34.4%)
 Female 153 (68.6%) 34 (75.6%) 79 (67.5%) 40 (65.6%)
Age, mean (SD) 52.8 (15.0) 52.4 (11.4) 53.1 (16.3) 52.3 (14.8)
IGT 101 (45.3%) 36 (80.0%) 53 (45.3) 12 (19.7%)
aSummary statistics of the prevalence of IGT and its association with plantar fasciitis, adjusted for the possible effect of gender and age.
Figure 1. Prevalence of isolated gastrocnemius tightness among 
the 3 groups expressed as a percentage.
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fascia and the gastrocnemius-soleus complex.4,23,27,28,46 
Increased tensional forces on the Achilles tendon (eg, due to 
gastrocnemius tightness) will result in increased transmis-
sion of forces on the plantar fascia in the stance phase of 
walking, causing plantar fasciitis.
The results also confirm a strong association between 
patients with other foot and ankle pathology and IGT, with 
a prevalence of 45.3% in this group. Patients without foot 
and ankle pathology were less likely to have IGT, with a 
prevalence of only 19.7% in this group. This prevalence is 
similar to the reported incidence of IGT in the normal popu-
lation (24%-44%).17
The average age of patients with plantar fasciitis in our 
study was 52.4 years. This falls within the reported peak age 
range for this condition, which is 40 to 60 years,8,9,38 with 
almost two-thirds of the affected patients being female (74%). 
The left and right feet were equally affected, and no differ-
ences were found between chronicity of symptoms and IGT.
The 80% IGT prevalence in our study is consistent 
with the existing literature and supports the notion that 
IGT is a strong risk factor for plantar fasciitis and may 
contribute to the development of other foot and ankle 
pathology. Patel et al40 reported an incidence of 83% of 
reduced ankle dorsiflexion in their study, looking at 
patients with plantar fasciitis, of which 57% had IGT. 
Similarly, DiGiovanni et al17 found a prevalence of IGT 
between 65% to 83% in patients with other foot and ankle 
pathology. In a cohort of 46 athletes with plantar fasciitis, 
Kibler et al26 found a prevalence of 86% reduced ankle 
dorsiflexion, but they did not determine the origin of the 
tightness. This current study shows that IGT does not 
invariably produce foot or ankle pathology as 19.7% of 
patients without foot and ankle pathology had a positive 
Silfverskiöld test. DiGiovanni et al17 reported an IGT 
prevalence of between 24% and 44% among the normal 
population without foot and ankle pathology.
Evidence suggests that a good proportion of patients 
with plantar fasciitis improve over time with conservative 
management alone. Therefore, when managing plantar 
fasciitis, nonoperative options must be exhausted prior to 
proceeding with operative techniques. The nonoperative 
options have been well described in literature and range 
from patient-oriented modalities such as rest, activity 
modification, ice packs, and analgesia52 to physical modal-
ities such as stretching15,16,24,31,52 and foot orthotics.36,42 
Recently, Engkananuwat et al20 found that simultaneous 
stretching of both the Achilles tendon and the plantar fas-
cia resulted in complete relief of plantar fasciitis symp-
toms after 4 weeks of treatment in 56% of their cohort. 
Orthotics commonly employed in the management of 
plantar fasciitis include night splints, viscoelastic heel 
cups, arch supports, and so forth. Failure to respond to 
these modalities can be followed by injections with ste-
roids,35 Botulinum-toxin (Botox),2,19 or platelet-rich 
plasma37,51; casting22,48; extracorporeal shockwave ther-
apy34,39,44; or low-level laser therapy.25,30 However, there 
will still be a subset of patients who fail to respond to 
the nonoperative modalities and subsequently develop 
chronic, recalcitrant symptoms that require operative 
intervention. Operative options include plantar fasciotomy 
or gastrocnemius soleus complex lengthening, done by 
either lengthening both the gastrocnemius and the soleus 
muscles or the gastrocnemius muscle alone. Based on the 
findings of this and previous studies that most patients 
with plantar fasciitis display IGT, a gastrocnemius muscle 
Table 3. Univariate Association Between Isolated Gastrocnemius Tightness (IGT), Plantar Fasciitis, and Other Characteristics.
All, N = 223 IGT, n = 101 (45.3%) No IGT, n = 122 (54.7%) P Value
Gender
 Male 70 (31.4%) 28 (27.7%) 42 (34.4%) .283
 Female 153 (68.6%) 73 (72.3%) 80 (65.6%)  
Age, mean (SD) 52.8 (15.) 53.5 (13.7) 52.1 (15.1) .500
Foot/ankle pathology
 Plantar fasciitis 45 (20.2%) 36 (80.0%) 9 (20.0%) <.001
 Other foot/ankle pathology 117 (52.5%) 53 (45.3%) 64 (54.7%)  
 No foot/ankle pathology 61 (27.3%) 12 (19.7%) 49 (80.3%)  
Figure 2. Prevalence of other foot and ankle pathology.
Nakale et al 275
release alone will seem to be adequate to allay the symp-
toms, possibly with reduced procedure related morbidity.
This view is supported by Aronow et al.4 Gastrocnemius 
recession has been noted to have a very high level of patient 
satisfaction in patients with isolated foot pain, 86% of 
whom had plantar fasciitis with grade B recommendation 
for midfoot problems including plantar fasciitis.14,32 Duthon 
et al18 reported that when a gastrocnemius recession was 
performed for isolated Achilles tendinopathy, the strength 
between the 2 legs was equal at 1 year. Abbassian et al1 
even advocated for the proximal release of the medial head 
of gastrocnemius alone. The authors argued that the medial 
head contributes a greater deal to generating plantarflexion 
power compared with the lateral head, and its release alone 
achieves satisfactory correction.
With the findings of this study and previous studies 
showing a strong association between IGT and plantar fas-
ciitis, it will be interesting to find out how IGT status 
changes over time as plantar fasciitis resolves. Therefore, 
future studies could assess the improvement of the 
Silfverskiöld test over time as plantar fasciitis resolves.
A limitation of this study is the relatively small study 
population even though it was adequately powered. A 
larger cohort would have been more representative. This 
study also did not assess some of the risk factors known 
to contribute to plantar fasciitis (eg, body mass index, 
occupation, and foot morphology such as cavovarus foot 
and pes planovalgus).5
Conclusion
This study suggests a very strong association between 
IGT and plantar fasciitis and a strong association between 
IGT and other foot and ankle pathology. This study also 
points to female gender and middle age (41 to 64 years) 
as additional risk factors for plantar fasciitis. The findings 
of this study suggest that IGT should be actively 
sought out early and treated, whether nonoperatively or 
operatively, when managing plantar fasciitis and other 
foot and ankle pathology.
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